Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: Working Out M0 Bipolar Androgen Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating M0 Bipolar Androgen Therapy for prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Australian and New Zealand Urogenital and Prostate Cancer Trials Group | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING